Home
About us
Our History
Mission
Executive Team
Board of Directors
Scientific Advisory Board
Pipeline
Overview
CM24
NT219
IM1240
Publications
Investors
Overview
News & Events
Press Releases
SEC Filings
Shareholders’ Meetings
Email Alerts
Corporate Governance
Contact us
menu
Home
About us
Pipeline
Investors
Contact Us
To Top
Archives:
Portfolio
Manipulating with our Portfolio
Categories
News and Events
Events
News
Publications
CM-24
more about CM-24
more about NT-219
NT-219
Posts
Purple Biotech will present a poster titled: ‘Phase 1 Study of CM24 in Combination with Nivolumab in Patients with Advanced Pancreatic Cancer – Survival, Potential Biomarker and Effect on Neutrophil Extracellular Traps (NETs)’ at the AACR Special Conference: Pancreatic Cancer, September 27-30, 2023. Presentation date and time: September 28 at 4:40 pm, 2023
Drug Discovery World article on NT219 poster publication on AACR23: “New drug could help overcome tumour resistance to treatment”
NT219 induces tumor PD-L1 expression and potentiates anti-PD-1efficacy
Purple Biotech to Participate in Canaccord Genuity’s 2023 Horizons in Oncology Virtual Conference on April 20, 2023.
Purple Biotech Presents NT219 Pre-Clinical Data at the AACR 2023 Annual Meeting.
Purple Biotech’s CEO Gil Efron is featured in Pharma’s Almanac sharing his insights in a Q&A executive interview. Read the full Q&A here.
Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.
Purple Biotech CEO Gil Efron is featured in Drug Development and Delivery Magazine in a Q&A executive interview. Read the full interview.
Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.
Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023
testing
By
afri-can
in Mar 13, 2023
sdfsdfdsf
Read more
Skip to content
Open toolbar
Accessibility Tools
Accessibility Tools
Increase Text
Increase Text
Decrease Text
Decrease Text
Grayscale
Grayscale
High Contrast
High Contrast
Negative Contrast
Negative Contrast
Light Background
Light Background
Links Underline
Links Underline
Readable Font
Readable Font
Reset
Reset